A patient with prior delayed inflammatory reaction to BDDE-based fillers requested HA treatment three years after resolution.
A total of 2 ml was injected bilaterally into the lateral and mid-to-lower face using linear retrograde and fanning techniques. At 12-month follow-up, volume and skin quality were restored with no inflammatory recurrence.
Neauvia Stimulate (PEG-crosslinked HA 26 mg/ml + 1% CaHA) was chosen for safety and dual volumizing/biostimulatory action.
Lorem ipsum dolor sit amet consectetur. Elementum feugiat risus morbi et nulla aliquam tortor adipiscing. Erat quam neque morbi ornare leo duis viverra massa est.